Meghan G Lubner1, Christine O Menias2, Michelle Agrons3, Kinan Alhalabi2, Venkata S Katabathina4, Khaled M Elsayes5, Perry J Pickhardt1. 1. 1 Department of Radiology, University of Wisconsin School of Medicine & Public Health, 600 Highland Ave, E3/311 Clinical Science Center, Madison, WI 53792-3252. 2. 2 Department of Radiology, Mayo Clinic, Phoenix, AZ. 3. 3 Department of Radiology, Baylor College of Medicine, Houston, TX. 4. 4 Department of Radiology, The University of Texas Health Science Center at San Antonio, San Antonio, TX. 5. 5 Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Abstract
OBJECTIVE: Graft-versus-host disease (GVHD) is a common complication of hematopoietic stem cell transplant (HSCT). GVHD predominantly affects the skin, gastrointestinal system and hepatobiliary systems. Imaging findings in the gastrointestinal tract include bowel wall thickening with mucosal enhancement, mesenteric edema, and vascular engorgement. In the hepatobiliary system, hepatosplenomegaly, periportal edema, bile duct dilatation, and gallbladder and biliary wall thickening are seen. Although the imaging findings of GVHD are nonspecific, with a known history of HSCT, GVHD should be considered. CONCLUSION: GVHD is a serious complication of HSCT, which involves multiple organ systems, with imaging manifestations most commonly seen in the gastrointestinal tract and hepatobiliary system. Knowledge of the imaging manifestations of GVHD, which alone may be relatively nonspecific, taken in conjunction with clinical history including the timing and type of HSCT, laboratory values, stool studies, and dermatologic findings can increase radiologist confidence in suggesting this diagnosis.
OBJECTIVE:Graft-versus-host disease (GVHD) is a common complication of hematopoietic stem cell transplant (HSCT). GVHD predominantly affects the skin, gastrointestinal system and hepatobiliary systems. Imaging findings in the gastrointestinal tract include bowel wall thickening with mucosal enhancement, mesenteric edema, and vascular engorgement. In the hepatobiliary system, hepatosplenomegaly, periportal edema, bile duct dilatation, and gallbladder and biliary wall thickening are seen. Although the imaging findings of GVHD are nonspecific, with a known history of HSCT, GVHD should be considered. CONCLUSION:GVHD is a serious complication of HSCT, which involves multiple organ systems, with imaging manifestations most commonly seen in the gastrointestinal tract and hepatobiliary system. Knowledge of the imaging manifestations of GVHD, which alone may be relatively nonspecific, taken in conjunction with clinical history including the timing and type of HSCT, laboratory values, stool studies, and dermatologic findings can increase radiologist confidence in suggesting this diagnosis.
Authors: Israt S Alam; Federico Simonetta; Lukas Scheller; Aaron T Mayer; Robert Negrin; Sanjiv S Gambhir; Surya Murty; Ophir Vermesh; Tomomi W Nobashi; Juliane K Lohmeyer; Toshihito Hirai; Jeanette Baker; Kenneth H Lau Journal: Cancer Res Date: 2020-09-08 Impact factor: 12.701
Authors: A Judit Machnitz; Janet R Reid; Michael R Acord; Asef B Khwaja; David M Biko; Rama S Ayyala; Sudha A Anupindi Journal: Pediatr Radiol Date: 2018-08-04
Authors: Mehrnam Amouei; Sara Momtazmanesh; Hoda Kavosi; Amir H Davarpanah; Ali Shirkhoda; Amir Reza Radmard Journal: Insights Imaging Date: 2022-09-04